You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure PPP-2. Indexed trends in EU potency/purity for major drug types, adjusting for population size, 2006–11

Drug type	2006	2007	2008	2009	2010	2011
Cannabis resin	100	101	109	106	116	120
Cocaine	100	106	101	82	93	105
Amphetamines	100	94	65	65	83	88
Ecstasy	100	125	108	102	130	166

Notes:

1. The trends represent the available information on national potency / purity for each drug in the EU Member States and Norway, weighted by country population sizes to form an overall EU trend. All series indexed to a base of 100 in 2006.

2. Countries missing drug price information for two or more consecutive years are not included in the trend calculations: the trend for amphetamine on seventeen countries (65 % of the EU population 15-64), cocaine on twenty-one countries (82 % of the EU population 15-64), ecstasy on eighteen countries (59 % of the EU population 15-64), and cannabis resin on fifteen countries (58 % of the EU population 15-64). Trends for other drugs are not available due to insufficient data.

3. Additionally, where 2011 data are missing (one country) 2010 purity are used; for missing 2006 data (one countries) 2007 potency/purity data are used; data missing for other years (four countries) have been interpolated from adjacent years.

Sources:

Potency / purity data: Reitox National Focal Points

Drug type	2006	2007	2008	2009	2010	2011
Cannabis resin	100	101	109	106	116	120
Cocaine	100	106	101	82	93	105
Amphetamines	100	94	65	65	83	88
Ecstasy	100	125	108	102	130	166

pppfig2

Demonstration	Reference	Type	Y Axis	X axis	Label	Width (%)	Height (px)	Y plotline	Y min,max values	series Markers
	szrfig1	column,column,line	Quantity (kg)\|Number of seizures$3
	szrfig2	column,column,line	Quantity (kg)\|Number of seizures$3
	gpsfig4a	line	%				500		0,30
	gpsfig1	column	%				500		0,25
	gpsfig2	column,column,point	Contiuation rates %\|LTP all adults$3						0,
	gpsfig18a	distribution	Estimated prevalence (%)						0
	gpsfig18b	distribution	Estimated prevalence (%)						0
	gpsfig20	column	%				600		0,20
	dlofig2	stackedBar	%				600
	dlofig3	line	Index (2006 = 100)			68
	dlofig3$	pie			1 135 701 reports (2011)	30
	dlofig4	line	Index (2006 = 100)			68
	dlofig4$	pie			915 541 reports (2011)	30
	dlofig5	line	Index (2006 = 100)			68
	dlofig5$	pie			179 418 reports (2011)	30
	drdfig12a	scatter	Ratio between DRD in 2003 and 2000	Number of DRD in 2000				1
	drdfig12b	scatter	Ratio between DRD in 2010/11 and 2003	Number of DRD in 2003				1
	hsrfig2	stackedColumn	Clients in substitution treatment
	dlofig1	line	Index (2006 = 100)						60,180
	drdfig1	column	Country and total number of DRD				600
	drdfig2	column	Proportion of DRD under the age of 25 (%)				600
	drdfig3	line	Mean age in years
	drdfig4	line	Mean age in years
	drdfig5a	line	Index (1990 = 100)
	drdfig5b	line	Index (1996 = 100)
	drdfig6	line	Index (1990 = 100 %)						80,160
	drdfig7a	column	Mortality rate per million
	drdfig7b	column,point	Rate per million
	drdfig8	line	Index (1985 = 100 %)						50,650
	drdfig9a	line	%						0,70
	drdfig9b	line	%
	drdfig9c	line	%
	drdfig10	column	Mean age in years				500
	drdfig11a	line	Index						0,300
	drdfig11b	line	Index
	drdfig11c	line	Index
	drdfig13a	line	Number of cases
	drdfig13b	line	Number of cases
	eyefig1a	line
	eyefig1b	line
	eyefig1c	line							0,
	eyefig1d	line	%			45	800
	eyefig1d$	line	%			45	800
	gpsfig3	column	%				500
	gpsfig4b	line	%
	gpsfig5	column	%
	gpsfig6	column	%
	gpsfig7	column	%
	gpsfig8a	line	%						0,
	gpsfig8b	line	%						0,
	gpsfig9a	column	%
	gpsfig9b	column	%
	gpsfig10	line	%
	gpsfig11	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig12a	line	%						0,
	gpsfig12b	line	%						0,
	gpsfig13	column,column,point	%
	gpsfig14a	line	%						0,
	gpsfig14b	line	%						0,
	gpsfig15	column	%
	gpsfig16	column,column,point	Continuation rates (%)\|LTP All adults$3						0,
	gpsfig17	column	%
	gpsfig21a	line	%						0,
	gpsfig21b	line	%						0,
	gpsfig22	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig23a	line	%
	gpsfig23b	line	%
	gpsfig23c	line	%
	gpsfig23d	line	%						0,
	gpsfig23e	line	%						0,
	hsrfig4	pie			% of prison population in OST	30
	inffig1a	line	New AIDS cases per million population				700		0,
	inffig1b	line	New AIDS cases per million population				700		0,
	inffig2a	line	Cases per million population						0,
	inffig2b	line	Cases per million population						0,
	inffig2c	line	Cases per million population
	inffig2d	line	Cases per million population
	inffig3a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	pppfig1	line	Index (2005 = 100)
	pppfig2	line	Index (2005 = 100)
	tdifig1a	line	%
	tdifig1b	line
	tdifig2a	pie				30
	tdifig2b	pie				50
	tdifig3a	line	%
	tdifig3b	line
	tdifig7	line	%			60			0,
	tdifig7$	stackedColumn	Numbers			38			0,50000
	hsrfig1b	stackedColumn	%































Distirbuted points with specific markers and colours	inffig6a	distribution	%							National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)

Download spreadsheet version (.xls)